Financial Statements

Jazz Pharmaceuticals plc (JAZZ)

$148.53

-1.00 (-0.67%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 1,1601,068842918-
Net Income -330239523447488
Stock Dividends --147-297-524431
Dividend Paid -----
Retained Earnings 8301,1601,068842918

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 257271200170-
Annual Depreciation 132365253162284
Capital Expenditure -46-379-182-131-114
Net PPE 343257271200170

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -948928920958
New Purchases -385-1,166-917-2,398-27
Intangible and Goodwill 9489289209581,828

Jazz Pharmaceuticals plc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Jazz Pharmaceuticals plc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.